Clinical Trial

[18F]-AraG PET Imaging in LA HNSCC

Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
This study will use \[18F\]-AraG PET/CT scans to monitor patients who have been diagnosed with locally advanced Head and Neck Squamous Cell carcinoma (LA-HNSCC), and are planning to undergo standard of care chemoradiotherapy for treatment.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-04.
Trial Details
NCT Number NCT07168785
Lead Sponsor Indiana University
Collaborators: CellSight Technologies, Inc.
Conditions Head and Neck Squamous Cell Carcinoma (HNSCC), Locally Advanced Head and Neck Squamous Cell Carcinoma
Enrollment 5 participants
Start Date 2026-09
Primary Completion 2027-06 (estimated)
Study Completion 2027-10 (estimated)
Updated on ClinicalTrials.gov 2026-07-22